相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
Joann M. Spinale et al.
KIDNEY INTERNATIONAL (2015)
Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease
Bjorn Meijers et al.
KIDNEY INTERNATIONAL (2015)
Rituximab for patients with nephrotic syndrome
Jae Il Shin et al.
LANCET (2015)
Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis
Claudio Musetti et al.
JOURNAL OF NEPHROLOGY (2015)
Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease
Tae-Hyun Yoo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Causes and pathogenesis of focal segmental glomerulosclerosis
Agnes B. Fogo
NATURE REVIEWS NEPHROLOGY (2015)
The Pathogenesis of Focal Segmental Glomerulosclerosis
J. Ashley Jefferson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Permeability Factors in Focal and Segmental Glomerulosclerosis
Jochen Reiser et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review
Andreas Kronbichler et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis
Jing Huang et al.
BMC MEDICINE (2014)
Glomerular Diseases: FSGS
Bhadran Bose et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Hype Cycle for Soluble Urokinase Receptor in FSGS: Passing the Trough of Disillusionment?
Bjorn Meijers et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Relationship between Serum Soluble Urokinase Plasminogen Activator Receptor Level and Steroid Responsiveness in FSGS
Furong Li et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Administration of Recombinant Soluble Urokinase Receptor Per Se Is Not Sufficient to Induce Podocyte Alterations and Proteinuria in Mice
Dominique Cathelin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Initial Steroid Sensitivity in Children with Steroid-Resistant Nephrotic Syndrome Predicts Post-Transplant Recurrence
Wen Y. Ding et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children
Aditi Sinha et al.
KIDNEY INTERNATIONAL (2014)
A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease
Takehiko Wada et al.
KIDNEY INTERNATIONAL (2014)
Elevated soluble urokinase receptors in focal segmental glomerulosclerosis: a role for IL-2?
Se Jin Park et al.
KIDNEY INTERNATIONAL (2014)
Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease
Rutger J. H. Maas et al.
KIDNEY INTERNATIONAL (2014)
Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?
Detlef Schloendorff
KIDNEY INTERNATIONAL (2014)
Soluble urokinase receptor in a toddler with focal segmental glomerulosclerosis
Tetsuya Kitao et al.
KIDNEY INTERNATIONAL (2014)
Serum levels of soluble urokinase plasminogen activator receptor in Japanese patients with chronic kidney disease
Yoshinori Taniguchi et al.
KIDNEY INTERNATIONAL (2014)
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
Bjorn Meijers et al.
KIDNEY INTERNATIONAL (2014)
Rituximab in Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis
Andreas Kronbichler et al.
NEPHRON CLINICAL PRACTICE (2014)
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance
Gabriel Cara-Fuentes et al.
PEDIATRIC NEPHROLOGY (2014)
Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis
Yutaka Harita et al.
PEDIATRIC NEPHROLOGY (2014)
Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome
Jutta Gellermann et al.
PEDIATRIC NEPHROLOGY (2014)
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation
Marianne Delville et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Rapamycin Promotes Podocyte Migration Through the Up-regulation of Urokinase Receptor
M. -J. Wu et al.
TRANSPLANTATION PROCEEDINGS (2014)
PITFALLS AND LIMITATIONS IN TRANSLATION FROM BIOMARKER DISCOVERY TO CLINICAL UTILITY IN PREDICTIVE AND PERSONALISED MEDICINE
Elisabeth Drucker et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome
Alfons Segarra et al.
NEFROLOGIA (2014)
Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis
Alfons Segarra et al.
NEFROLOGIA (2014)
Transmission of Glomerular Permeability Factor Soluble Urokinase Plasminogen Activator Receptor (suPAR) From a Mother to Child
Markus J. Kemper et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Management of Severe Recurrent Focal Segmental Glomerulosclerosis Through Circulating Soluble Urokinase Receptor Modification
Christian Morath et al.
AMERICAN JOURNAL OF THERAPEUTICS (2013)
Is There Clinical Value in Measuring suPAR Levels in FSGS?
Sanja Sever et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children: A Single-Center Report
Margret E. Bock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation
Seiichiro Shishido et al.
CLINICAL TRANSPLANTATION (2013)
Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1
Jessica J. Harris et al.
JOURNAL OF PATHOLOGY (2013)
Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis
Jing Huang et al.
KIDNEY INTERNATIONAL (2013)
Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model
C-C Cheng et al.
LUPUS (2013)
GLOMERULAR DISEASE 'suPAR'-exciting times for FSGS
J. Ashley Jefferson et al.
NATURE REVIEWS NEPHROLOGY (2013)
Circulating factor in FSGS: a black sheep in the suPAR family?
Howard Trachtman et al.
PEDIATRIC NEPHROLOGY (2013)
Serum suPAR in patients with FSGS: trash or treasure?
Rutger J. H. Maas et al.
PEDIATRIC NEPHROLOGY (2013)
Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome
Kristen Sgambat et al.
PEDIATRIC NEPHROLOGY (2013)
1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria
Jianchao Ma et al.
PLOS ONE (2013)
Fibroblast Growth Factor 23, Hepatocyte Growth Factor, Interleukin-6, High-Sensitivity C-Reactive Protein and Soluble Urokinase Plasminogen Activator Receptor. Inflammation Markers in Chronic Haemodialysis Patients?
G. Almroth et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates
Carlos R. Franco Palacios et al.
TRANSPLANTATION (2013)
Podocyte Effacement Closely Links to suPAR Levels at Time of Posttransplantation Focal Segmental Glomerulosclerosis Occurrence and Improves With Therapy
Nada Alachkar et al.
TRANSPLANTATION (2013)
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation
Rutger J. H. Maas et al.
BMC NEPHROLOGY (2013)
Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models
Sylvana M. L. de Mik et al.
BMC NEPHROLOGY (2013)
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
Elisabeth Drucker et al.
EPMA JOURNAL (2013)
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmo Diet and Cancer Study
M. Persson et al.
ATHEROSCLEROSIS (2012)
suPAR as a prognostic biomarker in sepsis
Katia Donadello et al.
BMC MEDICINE (2012)
NPHS2 Mutations in Indian Children with Sporadic Early Steroid Resistant Nephrotic Syndrome
Anil Vasudevan et al.
INDIAN PEDIATRICS (2012)
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury
Bin Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Serum-soluble urokinase receptor concentration in primary FSGS
Rutger J. H. Maas et al.
KIDNEY INTERNATIONAL (2012)
The podocyte cytoskeleton-key to a functioning glomerulus in health and disease
Gavin I. Welsh et al.
NATURE REVIEWS NEPHROLOGY (2012)
Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria
Bin Zhang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
New players in the pathogenesis of focal segmental glomerulosclerosis
Christoph Schell et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Acute Podocyte Vascular Endothelial Growth Factor (VEGF-A) Knockdown Disrupts alphaVbeta3 Integrin Signaling in the Glomerulus
Delma Veron et al.
PLOS ONE (2012)
The phenomenon of focal segmental glomerulosclerosis post-transplantation-a one-hit wonder?
Moin A. Saleem
PEDIATRIC NEPHROLOGY (2012)
TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation
Martin Bitzan et al.
PEDIATRIC NEPHROLOGY (2012)
Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study
Aletta E. Schutte et al.
THROMBOSIS RESEARCH (2012)
Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease
Lei Shen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
Thomas Huneck Haupt et al.
CRITICAL CARE (2012)
Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after Transplantation
Therese C. Jungraithmayr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
Alessia Fornoni et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
Anna Gustafsson et al.
BIOMARKER INSIGHTS (2011)
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
Ellen T. McCarthy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review
Modini Vinai et al.
PEDIATRIC TRANSPLANTATION (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Repeatability of published microarray gene expression analyses
John P. A. Ioannidis et al.
NATURE GENETICS (2009)
Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (Palb)
Deane S. Charba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity
Virginia J. Savin et al.
TRANSLATIONAL RESEARCH (2008)
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy
Ove Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy
S. R. Ostrowski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients
RY Gohh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation:: Clinical and genetic aspects
S Weber et al.
TRANSPLANTATION (2005)
Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome
C Ostergaard et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin
R Bertelli et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
IL-2-mediated upregulation of uPA and uPAR in natural killer cells
G Al-Atrash et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Transmission of glomerular permeability factor from a mother to her child
MJ Kemper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo
N Sidenius et al.
FEBS LETTERS (2000)
分享论文
